Impact of COVID-19 pandemic on childhood asthma and wheezing disorders

Yu-Han Xing1,2, Jayson Ka-Long Wong3, Yuan-Yuan Zhu4

  • 1School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, 518107, Guangdong, China. xingyh8@mail.sysu.edu.cn.

PubMed

Insights

Following COVID-19, pediatric wheezing admissions surged, with increased respiratory syncytial virus (RSV) and coinfections. Continued pathogen surveillance is vital for managing post-pandemic respiratory infections in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Epidemiology

Background:

  • The lifting of COVID-19 control measures has led to a resurgence of common respiratory pathogens.
  • The impact of these infections on children with wheezing illnesses remains a significant public health concern.

Purpose of the Study:

  • To investigate the trends and pathogen profiles of pediatric wheezing disorders before, during, and after the COVID-19 pandemic in Hong Kong.
  • To assess the impact of pandemic restrictions and their removal on wheezing-related hospital admissions in children.

Main Methods:

  • A prospective study of children (under 18 years) hospitalized for wheezing disorders from 2016 to 2025 in Hong Kong.
  • Nasopharyngeal aspirates were analyzed using rapid antigen detection, viral culture, and multiplex polymerase chain reaction (PCR).
  • Bacterial pathogens, including Chlamydia pneumoniae and Mycoplasma pneumoniae, were identified via cultures and PCR.

Main Results:

  • A total of 2499 children and 3272 admissions were analyzed, showing a reduction during the pandemic followed by a significant increase post-pandemic.
  • Post-pandemic, wheezing admissions, particularly for bronchiolitis, increased fivefold compared to the pandemic period (P < 0.001).
  • Respiratory syncytial virus (RSV) proportion increased significantly post-pandemic, especially in children under 5 (P < 0.01), with more frequent coinfections.

Conclusions:

  • The removal of COVID-19 restrictions has resulted in a resurgence of pediatric wheezing admissions and respiratory infections.
  • Ongoing monitoring of respiratory pathogens is essential in the post-pandemic era.
  • Preventive strategies are necessary to mitigate the impact of future health crises on pediatric respiratory health.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K